
Amoxicillin Production Cost Breakup from p-hydroxyphenylglycine
This study analyzes Amoxicillin Production from p-hydroxyphenylglycine, covering manufacturing, process flow, operating expenses, and financial considerations.
Details : Germany - based plant Q2 2026
This report provides an extensive cost evaluation of Amoxicillin production from p-hydroxyphenylglycine. The manufacturing process of Amoxicillin involves multiple steps. The process starts with dissolving p-hydroxyphenyl glycine is in anhydrous ethanol, Ethyl acetoacetate, and potassium hydroxide to form Dane salt, followed by its crystallization. The Dane salt is further reacted with pivaloyl chloride in the presence of a solvent such as methylene dichloride and 2,6-Lutidine, N,N-Dimethylacetamide, and 2,6-ethyl hexanoic acid as the catalysts to give a mixed anhydride complex. Finally, the mixture is reacted with 6-APA dissolved by triethylamine to produce enamine protected Amoxicillin, followed by hydrolysis with hydrochloric acid, separation, and purification, and centrifugation.
The project economic analysis provided in the report discusses a Germany-based plant:
Choose What's Right for You
Pay Via

Multi-Regional Cost Analyses
Compare plant and operation costs across regions with a consistent layout for standardized benchmarks for global expansion frameworks.
Feasibility Studies
Validate project viability with pre-built technical templates and financial assumptions calibrated to your industry.
Investment Analyses
Prioritise projects with side-by-side capital, return, and risk metrics aligned to your internal investment thresholds.
Techno-Economic Evaluations
Link process engineering data with fullchain economics to understand margins, breakeven points, and sensitivities.